SCHEMBL19863159

SCHEMBL19863159

c1ccc(-c2ccc(-n3c4ccccc4c4c5oc6ccccc6c5cc(-c5ccc(-n6c7ccccc7c7ccccc76)cc5)c43)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ATM Q13315 1/20 0.39
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HSD17B10 Q99714 2/20 0.36
POLB P06746 1/20 0.36
TSHR P16473 1/20 0.36
BRCA1 P38398 1/20 0.36
HDAC4 P56524 1/20 0.34
ALOX5 P09917 1/20 0.34
CDC14B O60729 1/20 0.33
CDC14A Q9UNH5 1/20 0.33
AHR P35869 1/20 0.33
PPARG P37231 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
NR2E3 Q9Y5X4 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
PLA2G2A P14555 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594157 0.93 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL18594321 0.93 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL18594048 0.92 KDM4E (0.39) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL19862856 0.91 ALDH1A1 (0.33) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL19863089 0.91 KDM4E (0.40) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL18594158 0.91 PLA2G2A (0.35) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL18594414 0.91 KDM4E (0.39) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL19862847 0.90 MEN1 (0.33) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL18594359 0.90 MEN1 (0.33) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL19862835 0.90 MEN1 (0.33) ALDH1A1MEN1KMT2AHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 KDM4E 1039/4885L3MBTL1 622/4885ATM 2081/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 KDM4E 1039/4885L3MBTL1 622/4885ATM 2081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.